

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to pheromone (GO:0019236) | 8.41652219 |
| 2 | cerebellar granule cell differentiation (GO:0021707) | 7.28871737 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.91871035 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.83277686 |
| 5 | cerebellar Purkinje cell differentiation (GO:0021702) | 5.74010858 |
| 6 | positive thymic T cell selection (GO:0045059) | 5.70326938 |
| 7 | locomotory exploration behavior (GO:0035641) | 5.66868108 |
| 8 | gamma-aminobutyric acid transport (GO:0015812) | 5.62574560 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.56644329 |
| 10 | cellular potassium ion homeostasis (GO:0030007) | 5.54546441 |
| 11 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 5.51860151 |
| 12 | neuronal action potential propagation (GO:0019227) | 5.50857251 |
| 13 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 5.48126263 |
| 14 | cell differentiation in hindbrain (GO:0021533) | 5.29898360 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.29847717 |
| 16 | neuromuscular process controlling posture (GO:0050884) | 5.20439295 |
| 17 | vocalization behavior (GO:0071625) | 5.19990549 |
| 18 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.17388031 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.16051291 |
| 20 | digestion (GO:0007586) | 5.07305437 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 5.02863601 |
| 22 | sodium ion export (GO:0071436) | 4.97457926 |
| 23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.94606230 |
| 24 | neurotransmitter secretion (GO:0007269) | 4.82133471 |
| 25 | hyperosmotic salinity response (GO:0042538) | 4.77641384 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.75046526 |
| 27 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.68570807 |
| 28 | synaptic vesicle exocytosis (GO:0016079) | 4.60297925 |
| 29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.57962340 |
| 30 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.49501298 |
| 31 | mitochondrial DNA replication (GO:0006264) | 4.45665857 |
| 32 | negative regulation of B cell apoptotic process (GO:0002903) | 4.40889444 |
| 33 | histone H3-K9 methylation (GO:0051567) | 4.38182842 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 4.38176163 |
| 35 | post-embryonic morphogenesis (GO:0009886) | 4.32329483 |
| 36 | interferon-gamma secretion (GO:0072643) | 4.25978928 |
| 37 | leukotriene biosynthetic process (GO:0019370) | 4.25873203 |
| 38 | glutamate secretion (GO:0014047) | 4.24307956 |
| 39 | positive T cell selection (GO:0043368) | 4.22945158 |
| 40 | hydrogen peroxide metabolic process (GO:0042743) | 4.11600567 |
| 41 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.10866653 |
| 42 | glutathione biosynthetic process (GO:0006750) | 4.10771505 |
| 43 | histone H3-K9 modification (GO:0061647) | 4.08939091 |
| 44 | layer formation in cerebral cortex (GO:0021819) | 4.07778493 |
| 45 | neuron-neuron synaptic transmission (GO:0007270) | 4.06859907 |
| 46 | neuromuscular process controlling balance (GO:0050885) | 4.04780848 |
| 47 | peroxisome fission (GO:0016559) | 4.03948540 |
| 48 | mannose metabolic process (GO:0006013) | 4.03806951 |
| 49 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 4.01873412 |
| 50 | neurotransmitter transport (GO:0006836) | 4.00730294 |
| 51 | long-term memory (GO:0007616) | 4.00228225 |
| 52 | dicarboxylic acid catabolic process (GO:0043649) | 4.00087767 |
| 53 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.99057259 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.94842196 |
| 55 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.94420132 |
| 56 | transmission of nerve impulse (GO:0019226) | 3.94027218 |
| 57 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.93671325 |
| 58 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.92954220 |
| 59 | actin nucleation (GO:0045010) | 3.91102964 |
| 60 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.90359654 |
| 61 | synaptic vesicle endocytosis (GO:0048488) | 3.89912386 |
| 62 | membrane budding (GO:0006900) | 3.85881090 |
| 63 | regulation of synaptic vesicle transport (GO:1902803) | 3.82974986 |
| 64 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.82383640 |
| 65 | energy homeostasis (GO:0097009) | 3.81347909 |
| 66 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.77349396 |
| 67 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.75744911 |
| 68 | proline transport (GO:0015824) | 3.75246885 |
| 69 | potassium ion import (GO:0010107) | 3.74514555 |
| 70 | exploration behavior (GO:0035640) | 3.74442682 |
| 71 | regulation of germinal center formation (GO:0002634) | 3.73733469 |
| 72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.72497743 |
| 73 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71766952 |
| 74 | potassium ion homeostasis (GO:0055075) | 3.70278511 |
| 75 | regulation of neurotransmitter levels (GO:0001505) | 3.67243030 |
| 76 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.64149547 |
| 77 | cysteine metabolic process (GO:0006534) | 3.63633101 |
| 78 | protein localization to synapse (GO:0035418) | 3.62928515 |
| 79 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.62778064 |
| 80 | Peyers patch development (GO:0048541) | 3.61704938 |
| 81 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.61704938 |
| 82 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.60772973 |
| 83 | adult walking behavior (GO:0007628) | 3.57005985 |
| 84 | glycine transport (GO:0015816) | 3.56222656 |
| 85 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.56177260 |
| 86 | membrane depolarization during action potential (GO:0086010) | 3.55751055 |
| 87 | dendritic spine morphogenesis (GO:0060997) | 3.53115230 |
| 88 | auditory behavior (GO:0031223) | 3.52726400 |
| 89 | cell communication by electrical coupling (GO:0010644) | 3.52253218 |
| 90 | neuron cell-cell adhesion (GO:0007158) | 3.49566960 |
| 91 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.46028322 |
| 92 | peptidyl-lysine dimethylation (GO:0018027) | 3.45232322 |
| 93 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 3.44570167 |
| 94 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.40464362 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 3.40287550 |
| 96 | regulation of synapse maturation (GO:0090128) | 3.38031101 |
| 97 | detection of temperature stimulus (GO:0016048) | 3.37614398 |
| 98 | cell migration in hindbrain (GO:0021535) | 3.37327832 |
| 99 | chemosensory behavior (GO:0007635) | 3.36633709 |
| 100 | regulation of hormone metabolic process (GO:0032350) | 3.35862812 |
| 101 | regulation of neurotransmitter secretion (GO:0046928) | 3.32680394 |
| 102 | regulation of postsynaptic membrane potential (GO:0060078) | 3.32433385 |
| 103 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 3.32250061 |
| 104 | short-chain fatty acid metabolic process (GO:0046459) | 3.31755152 |
| 105 | mating behavior (GO:0007617) | 3.31497811 |
| 106 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.30911562 |
| 107 | collecting duct development (GO:0072044) | 3.30610464 |
| 108 | dendrite morphogenesis (GO:0048813) | 3.29834973 |
| 109 | pyrimidine-containing compound salvage (GO:0008655) | 3.29491670 |
| 110 | pyrimidine nucleoside salvage (GO:0043097) | 3.29491670 |
| 111 | establishment of nucleus localization (GO:0040023) | 3.29312782 |
| 112 | membrane hyperpolarization (GO:0060081) | 3.27873604 |
| 113 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.27559348 |
| 114 | mitochondrion transport along microtubule (GO:0047497) | 3.27559348 |
| 115 | C4-dicarboxylate transport (GO:0015740) | 3.26187170 |
| 116 | neuromuscular process (GO:0050905) | 3.25283663 |
| 117 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.24398655 |
| 118 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.22372485 |
| 119 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.21643521 |
| 120 | membrane depolarization (GO:0051899) | 3.21084121 |
| 121 | DNA deamination (GO:0045006) | 3.20597145 |
| 122 | regulation of B cell apoptotic process (GO:0002902) | 3.18150576 |
| 123 | folic acid metabolic process (GO:0046655) | 3.17653794 |
| 124 | cellular response to fluid shear stress (GO:0071498) | 3.17072791 |
| 125 | positive regulation of membrane potential (GO:0045838) | 3.16746034 |
| 126 | multicellular organismal movement (GO:0050879) | 3.16542764 |
| 127 | musculoskeletal movement (GO:0050881) | 3.16542764 |
| 128 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.16390312 |
| 129 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.16004900 |
| 130 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.12780943 |
| 131 | negative regulation of hormone metabolic process (GO:0032351) | 3.12780943 |
| 132 | mechanosensory behavior (GO:0007638) | 3.11286751 |
| 133 | cellular sodium ion homeostasis (GO:0006883) | 3.10592742 |
| 134 | icosanoid biosynthetic process (GO:0046456) | 3.09968092 |
| 135 | fatty acid derivative biosynthetic process (GO:1901570) | 3.09968092 |
| 136 | immunoglobulin mediated immune response (GO:0016064) | 3.09630038 |
| 137 | peptide catabolic process (GO:0043171) | 3.09519845 |
| 138 | regulation of acrosome reaction (GO:0060046) | 3.08815804 |
| 139 | water-soluble vitamin metabolic process (GO:0006767) | 3.08698218 |
| 140 | regulation of neurotransmitter transport (GO:0051588) | 3.05031752 |
| 141 | response to auditory stimulus (GO:0010996) | 3.04795668 |
| 142 | thymic T cell selection (GO:0045061) | 3.02609627 |
| 143 | activation of protein kinase A activity (GO:0034199) | 3.02018643 |
| 144 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.01218094 |
| 145 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.01124305 |
| 146 | synapse assembly (GO:0007416) | 2.98373737 |
| 147 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.96655205 |
| 148 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.96534940 |
| 149 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.96534940 |
| 150 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.95884024 |
| 151 | gonadal mesoderm development (GO:0007506) | 2.95477861 |
| 152 | neuromuscular synaptic transmission (GO:0007274) | 2.94579313 |
| 153 | regulation of respiratory system process (GO:0044065) | 2.90377758 |
| 154 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.89980776 |
| 155 | B cell receptor signaling pathway (GO:0050853) | 2.89677312 |
| 156 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.89102462 |
| 157 | short-term memory (GO:0007614) | 2.88485834 |
| 158 | mitochondrial DNA metabolic process (GO:0032042) | 2.88407926 |
| 159 | regulation of respiratory gaseous exchange (GO:0043576) | 2.86369616 |
| 160 | regulation of response to osmotic stress (GO:0047484) | 2.86155850 |
| 161 | positive regulation of dendritic spine development (GO:0060999) | 2.85311388 |
| 162 | auditory receptor cell stereocilium organization (GO:0060088) | 2.83741448 |
| 163 | spinal cord development (GO:0021510) | 2.82963224 |
| 164 | regulation of penile erection (GO:0060405) | 2.81209467 |
| 165 | innervation (GO:0060384) | 2.80684018 |
| 166 | synapse organization (GO:0050808) | 2.80264678 |
| 167 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79989100 |
| 168 | peptide biosynthetic process (GO:0043043) | 2.79881880 |
| 169 | positive regulation of macrophage cytokine production (GO:0060907) | 2.78061885 |
| 170 | positive regulation of respiratory burst (GO:0060267) | 2.77309761 |
| 171 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.76106187 |
| 172 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.73085253 |
| 173 | negative regulation of osteoblast proliferation (GO:0033689) | 2.71208072 |
| 174 | tetrapyrrole metabolic process (GO:0033013) | 2.69855932 |
| 175 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.67906688 |
| 176 | oxaloacetate metabolic process (GO:0006107) | 2.67779870 |
| 177 | cytidine deamination (GO:0009972) | 2.64616094 |
| 178 | cytidine metabolic process (GO:0046087) | 2.64616094 |
| 179 | cytidine catabolic process (GO:0006216) | 2.64616094 |
| 180 | leukotriene metabolic process (GO:0006691) | 2.61781569 |
| 181 | establishment of mitochondrion localization (GO:0051654) | 2.59636840 |
| 182 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.59061863 |
| 183 | protein insertion into membrane (GO:0051205) | 2.57744816 |
| 184 | regulation of hypersensitivity (GO:0002883) | 2.56526276 |
| 185 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.55724919 |
| 186 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.52947482 |
| 187 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.51961308 |
| 188 | vitamin A metabolic process (GO:0006776) | 2.50304384 |
| 189 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.47416011 |
| 190 | N-acetylglucosamine metabolic process (GO:0006044) | 2.45892365 |
| 191 | regulation of respiratory burst (GO:0060263) | 2.44342911 |
| 192 | rhodopsin mediated signaling pathway (GO:0016056) | 2.44176523 |
| 193 | positive regulation of prostaglandin secretion (GO:0032308) | 2.43970822 |
| 194 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.42660042 |
| 195 | cobalamin metabolic process (GO:0009235) | 10.0940886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.38131148 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.78542091 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.69389398 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.38400743 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.01825306 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.98153099 |
| 7 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.97292583 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.92993009 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.92605805 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.92605805 |
| 11 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.77065299 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.76862908 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.74932842 |
| 14 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65885000 |
| 15 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58586479 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39956209 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38932888 |
| 18 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.31327212 |
| 19 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.30566330 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.29501997 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.27184426 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26837456 |
| 23 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26755343 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.26669113 |
| 25 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.26202326 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.22821949 |
| 27 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.21370424 |
| 28 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21304057 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15999335 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.14929759 |
| 31 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12556767 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10484628 |
| 33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.97694027 |
| 34 | * P68_20966046_ChIP-Seq_HELA_Human | 1.96400742 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.95580188 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90202491 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.89921392 |
| 38 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.88443785 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84804632 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80046545 |
| 41 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.77853373 |
| 42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.77166140 |
| 43 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.75086453 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70083865 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69019002 |
| 46 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.68650930 |
| 47 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.68309820 |
| 48 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.68152395 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.66853883 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66529043 |
| 51 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.63828481 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61423916 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.60822085 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.60243241 |
| 55 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.57907621 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55641419 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.54866147 |
| 58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53470164 |
| 59 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.52887065 |
| 60 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.51734810 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51339001 |
| 62 | * P300_27268052_Chip-Seq_Bcells_Human | 1.48854328 |
| 63 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47704542 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47173773 |
| 65 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.46138165 |
| 66 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.40731918 |
| 67 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.39495820 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.39211452 |
| 69 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.38712684 |
| 70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.36223931 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35568246 |
| 72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.33127433 |
| 73 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.31249514 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31158199 |
| 75 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.29747309 |
| 76 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29312090 |
| 77 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.28976134 |
| 78 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.27329672 |
| 79 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26652740 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25935698 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25415750 |
| 82 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.24807500 |
| 83 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24734443 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24028285 |
| 85 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23471210 |
| 86 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.22457250 |
| 87 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.22457250 |
| 88 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.22457250 |
| 89 | AR_19668381_ChIP-Seq_PC3_Human | 1.22303103 |
| 90 | ERA_21632823_ChIP-Seq_H3396_Human | 1.22156648 |
| 91 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22035013 |
| 92 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.21263228 |
| 93 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19197311 |
| 94 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.19066083 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18846453 |
| 96 | * RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18704757 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18472685 |
| 98 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18310581 |
| 99 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18166002 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16181163 |
| 101 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.15963016 |
| 102 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.15555964 |
| 103 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.15387021 |
| 104 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.15114847 |
| 105 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.14940747 |
| 106 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14501231 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14449835 |
| 108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14278829 |
| 109 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14223353 |
| 110 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14067623 |
| 111 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12987888 |
| 112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11926051 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10284033 |
| 114 | SA1_27219007_Chip-Seq_Bcells_Human | 1.10140590 |
| 115 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09843867 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09773354 |
| 117 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09415763 |
| 118 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09406780 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09271386 |
| 120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09052025 |
| 121 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08797380 |
| 122 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07673070 |
| 123 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06769166 |
| 124 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05330984 |
| 125 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.04772387 |
| 126 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04770100 |
| 127 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04525724 |
| 128 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04107652 |
| 129 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03303828 |
| 130 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02634107 |
| 131 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02149189 |
| 132 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.01271001 |
| 133 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00594898 |
| 134 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00255259 |
| 135 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98676017 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98657078 |
| 137 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98277568 |
| 138 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.98032964 |
| 139 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97645208 |
| 140 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.97334005 |
| 141 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97328643 |
| 142 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95998331 |
| 143 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95692804 |
| 144 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95357783 |
| 145 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.94547611 |
| 146 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.94250659 |
| 147 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.93133760 |
| 148 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.92538450 |
| 149 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91914526 |
| 150 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.91431955 |
| 151 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.91257936 |
| 152 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90804139 |
| 153 | * FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90190727 |
| 154 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.90125698 |
| 155 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89766162 |
| 156 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.89763205 |
| 157 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88652280 |
| 158 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.88636448 |
| 159 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88428796 |
| 160 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88258536 |
| 161 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.87484362 |
| 162 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86591389 |
| 163 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86466755 |
| 164 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.85854820 |
| 165 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85622609 |
| 166 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85052612 |
| 167 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.84306658 |
| 168 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.83989624 |
| 169 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82692979 |
| 170 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.82307015 |
| 171 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82307015 |
| 172 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.81490998 |
| 173 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81447692 |
| 174 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81301800 |
| 175 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.81016537 |
| 176 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.80612592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009046_muscle_twitch | 5.08625302 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.00550708 |
| 3 | MP0003011_delayed_dark_adaptation | 3.93322552 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 3.81171801 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.33840798 |
| 6 | MP0003195_calcinosis | 3.24248403 |
| 7 | MP0008569_lethality_at_weaning | 3.21900013 |
| 8 | MP0002064_seizures | 3.11021490 |
| 9 | MP0002272_abnormal_nervous_system | 3.07074764 |
| 10 | MP0009745_abnormal_behavioral_response | 2.99720803 |
| 11 | MP0003880_abnormal_central_pattern | 2.98048207 |
| 12 | MP0004270_analgesia | 2.91896439 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.90929131 |
| 14 | MP0009278_abnormal_bone_marrow | 2.84242888 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.67663531 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.65939295 |
| 17 | MP0002063_abnormal_learning/memory/cond | 2.65268858 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.56568480 |
| 19 | MP0002184_abnormal_innervation | 2.55963333 |
| 20 | MP0003136_yellow_coat_color | 2.51624350 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.48938918 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 2.47807914 |
| 23 | * MP0002067_abnormal_sensory_capabilities | 2.44837386 |
| 24 | MP0001486_abnormal_startle_reflex | 2.41293749 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.37879020 |
| 26 | MP0004858_abnormal_nervous_system | 2.34070916 |
| 27 | MP0001873_stomach_inflammation | 2.33475203 |
| 28 | MP0001501_abnormal_sleep_pattern | 2.31552323 |
| 29 | MP0001440_abnormal_grooming_behavior | 2.31184418 |
| 30 | MP0004142_abnormal_muscle_tone | 2.24778882 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 2.17158373 |
| 32 | MP0002733_abnormal_thermal_nociception | 2.09824729 |
| 33 | MP0002735_abnormal_chemical_nociception | 2.03585124 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 2.02533533 |
| 35 | MP0008995_early_reproductive_senescence | 2.00130062 |
| 36 | MP0000955_abnormal_spinal_cord | 1.94187373 |
| 37 | MP0001970_abnormal_pain_threshold | 1.93773127 |
| 38 | MP0002736_abnormal_nociception_after | 1.88416942 |
| 39 | MP0004885_abnormal_endolymph | 1.85177201 |
| 40 | MP0000681_abnormal_thyroid_gland | 1.82642727 |
| 41 | MP0000685_abnormal_immune_system | 1.81315912 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.74851959 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.67099899 |
| 44 | MP0003879_abnormal_hair_cell | 1.66213132 |
| 45 | MP0000778_abnormal_nervous_system | 1.64161730 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.63555903 |
| 47 | MP0005387_immune_system_phenotype | 1.61542953 |
| 48 | MP0001790_abnormal_immune_system | 1.61542953 |
| 49 | MP0004924_abnormal_behavior | 1.55686154 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.55686154 |
| 51 | MP0000678_abnormal_parathyroid_gland | 1.55077101 |
| 52 | MP0003122_maternal_imprinting | 1.54966027 |
| 53 | * MP0002066_abnormal_motor_capabilities/c | 1.53043361 |
| 54 | MP0003632_abnormal_nervous_system | 1.51916276 |
| 55 | MP0005365_abnormal_bile_salt | 1.51175191 |
| 56 | MP0003329_amyloid_beta_deposits | 1.50701567 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.47573834 |
| 58 | MP0004811_abnormal_neuron_physiology | 1.44839990 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.43496796 |
| 60 | MP0000538_abnormal_urinary_bladder | 1.41795493 |
| 61 | MP0004742_abnormal_vestibular_system | 1.41163366 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41133393 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.37130043 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.36480513 |
| 65 | MP0003633_abnormal_nervous_system | 1.34071491 |
| 66 | MP0006072_abnormal_retinal_apoptosis | 1.33859139 |
| 67 | MP0002909_abnormal_adrenal_gland | 1.33533745 |
| 68 | MP0008872_abnormal_physiological_respon | 1.33227646 |
| 69 | MP0003283_abnormal_digestive_organ | 1.29753033 |
| 70 | MP0005394_taste/olfaction_phenotype | 1.29693148 |
| 71 | MP0005499_abnormal_olfactory_system | 1.29693148 |
| 72 | MP0001664_abnormal_digestion | 1.28680411 |
| 73 | MP0005076_abnormal_cell_differentiation | 1.27618500 |
| 74 | MP0003787_abnormal_imprinting | 1.26954924 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.26442265 |
| 76 | MP0004043_abnormal_pH_regulation | 1.26180218 |
| 77 | MP0003631_nervous_system_phenotype | 1.25983638 |
| 78 | MP0000372_irregular_coat_pigmentation | 1.25111075 |
| 79 | MP0003303_peritoneal_inflammation | 1.24630678 |
| 80 | MP0002152_abnormal_brain_morphology | 1.20704092 |
| 81 | MP0001502_abnormal_circadian_rhythm | 1.19411514 |
| 82 | MP0005671_abnormal_response_to | 1.18597553 |
| 83 | MP0001485_abnormal_pinna_reflex | 1.17393565 |
| 84 | MP0002653_abnormal_ependyma_morphology | 1.15407945 |
| 85 | MP0001661_extended_life_span | 1.12531157 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 1.11089267 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 1.10666742 |
| 88 | MP0002229_neurodegeneration | 1.10379546 |
| 89 | MP0003045_fibrosis | 1.10213292 |
| 90 | MP0003718_maternal_effect | 1.09911028 |
| 91 | MP0001764_abnormal_homeostasis | 1.07795730 |
| 92 | MP0005310_abnormal_salivary_gland | 1.07634114 |
| 93 | MP0006276_abnormal_autonomic_nervous | 1.06920759 |
| 94 | MP0001835_abnormal_antigen_presentation | 1.06756990 |
| 95 | MP0003137_abnormal_impulse_conducting | 1.06512846 |
| 96 | MP0003690_abnormal_glial_cell | 1.05321309 |
| 97 | MP0003638_abnormal_response/metabolism_ | 1.03912040 |
| 98 | MP0000920_abnormal_myelination | 1.03349805 |
| 99 | MP0001963_abnormal_hearing_physiology | 1.02284991 |
| 100 | MP0001348_abnormal_lacrimal_gland | 1.02086701 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 1.01638932 |
| 102 | MP0001545_abnormal_hematopoietic_system | 1.01638932 |
| 103 | MP0002752_abnormal_somatic_nervous | 1.00869402 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.99957373 |
| 105 | MP0005083_abnormal_biliary_tract | 0.98290435 |
| 106 | MP0005647_abnormal_sex_gland | 0.97207538 |
| 107 | MP0001800_abnormal_humoral_immune | 0.96278984 |
| 108 | MP0001984_abnormal_olfaction | 0.94736113 |
| 109 | MP0005646_abnormal_pituitary_gland | 0.93626100 |
| 110 | MP0000371_diluted_coat_color | 0.91647199 |
| 111 | MP0003866_abnormal_defecation | 0.88649059 |
| 112 | MP0004147_increased_porphyrin_level | 0.87368289 |
| 113 | MP0003634_abnormal_glial_cell | 0.85836650 |
| 114 | MP0004808_abnormal_hematopoietic_stem | 0.85103381 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.82826503 |
| 116 | MP0002019_abnormal_tumor_incidence | 0.82628442 |
| 117 | MP0001666_abnormal_nutrient_absorption | 0.81486587 |
| 118 | MP0003861_abnormal_nervous_system | 0.81272241 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.80203578 |
| 120 | MP0000013_abnormal_adipose_tissue | 0.80060362 |
| 121 | MP0008961_abnormal_basal_metabolism | 0.78428190 |
| 122 | MP0002166_altered_tumor_susceptibility | 0.77869846 |
| 123 | MP0002138_abnormal_hepatobiliary_system | 0.77669929 |
| 124 | MP0005253_abnormal_eye_physiology | 0.77049462 |
| 125 | MP0006292_abnormal_olfactory_placode | 0.77028942 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.77017156 |
| 127 | MP0010769_abnormal_survival | 0.76040108 |
| 128 | MP0005075_abnormal_melanosome_morpholog | 0.73453797 |
| 129 | MP0003121_genomic_imprinting | 0.73298686 |
| 130 | MP0010768_mortality/aging | 0.73156406 |
| 131 | MP0005025_abnormal_response_to | 0.72914371 |
| 132 | MP0002638_abnormal_pupillary_reflex | 0.72306011 |
| 133 | MP0001765_abnormal_ion_homeostasis | 0.72197788 |
| 134 | MP0000579_abnormal_nail_morphology | 0.71717044 |
| 135 | MP0008874_decreased_physiological_sensi | 0.71371060 |
| 136 | MP0004264_abnormal_extraembryonic_tissu | 0.71202315 |
| 137 | MP0002069_abnormal_eating/drinking_beha | 0.70392981 |
| 138 | MP0001299_abnormal_eye_distance/ | 0.70377403 |
| 139 | MP0002098_abnormal_vibrissa_morphology | 0.70339802 |
| 140 | MP0002723_abnormal_immune_serum | 0.70190224 |
| 141 | MP0004233_abnormal_muscle_weight | 0.69968135 |
| 142 | MP0005448_abnormal_energy_balance | 0.69831311 |
| 143 | MP0002332_abnormal_exercise_endurance | 0.69806203 |
| 144 | MP0005636_abnormal_mineral_homeostasis | 0.68756070 |
| 145 | MP0002082_postnatal_lethality | 0.68664530 |
| 146 | MP0010770_preweaning_lethality | 0.68664530 |
| 147 | MP0000026_abnormal_inner_ear | 0.68029216 |
| 148 | MP0000716_abnormal_immune_system | 0.67876469 |
| 149 | MP0001943_abnormal_respiration | 0.67711643 |
| 150 | MP0005501_abnormal_skin_physiology | 0.67501993 |
| 151 | MP0004085_abnormal_heartbeat | 0.67444668 |
| 152 | MP0005266_abnormal_metabolism | 0.67432618 |
| 153 | MP0010386_abnormal_urinary_bladder | 0.66356872 |
| 154 | MP0004215_abnormal_myocardial_fiber | 0.65826831 |
| 155 | MP0005391_vision/eye_phenotype | 0.65261706 |
| 156 | MP0005167_abnormal_blood-brain_barrier | 0.61380978 |
| 157 | MP0000569_abnormal_digit_pigmentation | 0.59898427 |
| 158 | MP0000639_abnormal_adrenal_gland | 0.59159138 |
| 159 | MP0003123_paternal_imprinting | 0.58895462 |
| 160 | MP0000631_abnormal_neuroendocrine_gland | 0.57600814 |
| 161 | MP0003890_abnormal_embryonic-extraembry | 0.56785136 |
| 162 | MP0000751_myopathy | 0.56782217 |
| 163 | MP0005171_absent_coat_pigmentation | 0.56762800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 7.09020644 |
| 2 | Progressive cerebellar ataxia (HP:0002073) | 6.49409769 |
| 3 | Action tremor (HP:0002345) | 6.32291546 |
| 4 | Visual hallucinations (HP:0002367) | 5.14313572 |
| 5 | Focal motor seizures (HP:0011153) | 4.98723046 |
| 6 | Focal seizures (HP:0007359) | 4.97161514 |
| 7 | Febrile seizures (HP:0002373) | 4.96686684 |
| 8 | Progressive external ophthalmoplegia (HP:0000590) | 4.92845169 |
| 9 | Myokymia (HP:0002411) | 4.73661096 |
| 10 | Microvesicular hepatic steatosis (HP:0001414) | 4.70336790 |
| 11 | Gaze-evoked nystagmus (HP:0000640) | 4.61045722 |
| 12 | Dysdiadochokinesis (HP:0002075) | 4.58696085 |
| 13 | Atonic seizures (HP:0010819) | 4.52501932 |
| 14 | Congenital stationary night blindness (HP:0007642) | 4.32896426 |
| 15 | Abnormality of the lower motor neuron (HP:0002366) | 4.25552091 |
| 16 | Scanning speech (HP:0002168) | 4.23075352 |
| 17 | Chronic sinusitis (HP:0011109) | 4.12193124 |
| 18 | Epileptic encephalopathy (HP:0200134) | 4.07393479 |
| 19 | Hemiplegia (HP:0002301) | 4.03709351 |
| 20 | Hemiparesis (HP:0001269) | 4.00374439 |
| 21 | Tubulointerstitial nephritis (HP:0001970) | 3.98760449 |
| 22 | Hypoproteinemia (HP:0003075) | 3.94176009 |
| 23 | Impaired smooth pursuit (HP:0007772) | 3.91706520 |
| 24 | Dysmetric saccades (HP:0000641) | 3.90261295 |
| 25 | Intention tremor (HP:0002080) | 3.87273632 |
| 26 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.79016791 |
| 27 | Genetic anticipation (HP:0003743) | 3.76774196 |
| 28 | Absence seizures (HP:0002121) | 3.70526357 |
| 29 | Broad-based gait (HP:0002136) | 3.45548108 |
| 30 | Dysmetria (HP:0001310) | 3.44996148 |
| 31 | Diplopia (HP:0000651) | 3.43272209 |
| 32 | Abnormality of binocular vision (HP:0011514) | 3.43272209 |
| 33 | Horizontal nystagmus (HP:0000666) | 3.36047226 |
| 34 | Cellulitis (HP:0100658) | 3.34803773 |
| 35 | Goiter (HP:0000853) | 3.32589667 |
| 36 | Dialeptic seizures (HP:0011146) | 3.32396888 |
| 37 | Generalized tonic-clonic seizures (HP:0002069) | 3.31684849 |
| 38 | Persistence of primary teeth (HP:0006335) | 3.23386002 |
| 39 | Tetraplegia (HP:0002445) | 3.21080142 |
| 40 | Annular pancreas (HP:0001734) | 3.18063172 |
| 41 | Stridor (HP:0010307) | 3.17415841 |
| 42 | Truncal ataxia (HP:0002078) | 3.16941410 |
| 43 | Steatorrhea (HP:0002570) | 3.12782386 |
| 44 | Carpal bone hypoplasia (HP:0001498) | 3.12411061 |
| 45 | Prostate neoplasm (HP:0100787) | 3.10885376 |
| 46 | Status epilepticus (HP:0002133) | 3.05534689 |
| 47 | Rough bone trabeculation (HP:0100670) | 2.97822564 |
| 48 | External ophthalmoplegia (HP:0000544) | 2.94358952 |
| 49 | Gout (HP:0001997) | 2.93903311 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.90627608 |
| 51 | Obstructive lung disease (HP:0006536) | 2.90627608 |
| 52 | Neoplasm of the heart (HP:0100544) | 2.85266773 |
| 53 | Postural tremor (HP:0002174) | 2.81993901 |
| 54 | Recurrent bronchitis (HP:0002837) | 2.81787621 |
| 55 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.81027493 |
| 56 | Bronchomalacia (HP:0002780) | 2.78074781 |
| 57 | Poor eye contact (HP:0000817) | 2.77106810 |
| 58 | Glucose intolerance (HP:0000833) | 2.74969855 |
| 59 | Abnormality of B cell number (HP:0010975) | 2.71204485 |
| 60 | Muscle fiber splitting (HP:0003555) | 2.71013557 |
| 61 | Exocrine pancreatic insufficiency (HP:0001738) | 2.69501601 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.67916125 |
| 63 | Abnormality of the corticospinal tract (HP:0002492) | 2.65883140 |
| 64 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.64010814 |
| 65 | Apathy (HP:0000741) | 2.63862455 |
| 66 | Ventricular fibrillation (HP:0001663) | 2.63485687 |
| 67 | Depressed nasal tip (HP:0000437) | 2.62643669 |
| 68 | Abnormal social behavior (HP:0012433) | 2.57779288 |
| 69 | Impaired social interactions (HP:0000735) | 2.57779288 |
| 70 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.57624146 |
| 71 | Abnormality of the prostate (HP:0008775) | 2.55478731 |
| 72 | Agitation (HP:0000713) | 2.55196282 |
| 73 | Depression (HP:0000716) | 2.51601545 |
| 74 | Verrucae (HP:0200043) | 2.51557756 |
| 75 | Papilloma (HP:0012740) | 2.51557756 |
| 76 | Recurrent pneumonia (HP:0006532) | 2.51117046 |
| 77 | Nonprogressive disorder (HP:0003680) | 2.48545880 |
| 78 | Abnormality of saccadic eye movements (HP:0000570) | 2.47529428 |
| 79 | Flat acetabular roof (HP:0003180) | 2.45939362 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.45872888 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.45872888 |
| 82 | Diminished motivation (HP:0000745) | 2.45385287 |
| 83 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.44045489 |
| 84 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.44045489 |
| 85 | Meningitis (HP:0001287) | 2.43884999 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 2.42418416 |
| 87 | Amyotrophic lateral sclerosis (HP:0007354) | 2.40179750 |
| 88 | B lymphocytopenia (HP:0010976) | 2.37943038 |
| 89 | Seborrheic dermatitis (HP:0001051) | 2.37177644 |
| 90 | Sepsis (HP:0100806) | 2.36282385 |
| 91 | Hyperventilation (HP:0002883) | 2.34284606 |
| 92 | Progressive muscle weakness (HP:0003323) | 2.33227302 |
| 93 | Limb ataxia (HP:0002070) | 2.32534881 |
| 94 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.29546900 |
| 95 | Oligodactyly (hands) (HP:0001180) | 2.28788611 |
| 96 | Abnormal glucose tolerance (HP:0001952) | 2.27183832 |
| 97 | Abnormal trabecular bone morphology (HP:0100671) | 2.26746837 |
| 98 | Fat malabsorption (HP:0002630) | 2.25788721 |
| 99 | Bilateral microphthalmos (HP:0007633) | 2.23774331 |
| 100 | Anxiety (HP:0000739) | 2.23427934 |
| 101 | J-shaped sella turcica (HP:0002680) | 2.20277630 |
| 102 | Spinal muscular atrophy (HP:0007269) | 2.19916005 |
| 103 | Abnormality of male internal genitalia (HP:0000022) | 2.19767452 |
| 104 | Hyperthyroidism (HP:0000836) | 2.18867646 |
| 105 | Amblyopia (HP:0000646) | 2.18360876 |
| 106 | Osteomyelitis (HP:0002754) | 2.18263174 |
| 107 | Barrel-shaped chest (HP:0001552) | 2.17883742 |
| 108 | Hand muscle atrophy (HP:0009130) | 2.17845548 |
| 109 | Hyperuricemia (HP:0002149) | 2.16073125 |
| 110 | Increased purine levels (HP:0004368) | 2.16073125 |
| 111 | Ankle clonus (HP:0011448) | 2.12863094 |
| 112 | Clumsiness (HP:0002312) | 2.07321998 |
| 113 | Fetal akinesia sequence (HP:0001989) | 2.04406898 |
| 114 | Down-sloping shoulders (HP:0200021) | 2.04289296 |
| 115 | Drooling (HP:0002307) | 2.02608393 |
| 116 | Excessive salivation (HP:0003781) | 2.02608393 |
| 117 | Abnormal eating behavior (HP:0100738) | 2.01501735 |
| 118 | Recurrent otitis media (HP:0000403) | 2.00941560 |
| 119 | Gait ataxia (HP:0002066) | 2.00828429 |
| 120 | Abnormality of the pleura (HP:0002103) | 1.97580794 |
| 121 | Spastic gait (HP:0002064) | 1.97277845 |
| 122 | Aqueductal stenosis (HP:0002410) | 1.96285049 |
| 123 | Postural instability (HP:0002172) | 1.93954095 |
| 124 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.90064703 |
| 125 | Aplasia of the phalanges of the hand (HP:0009802) | 1.90064703 |
| 126 | Aplasia involving bones of the extremities (HP:0009825) | 1.90064703 |
| 127 | Poikiloderma (HP:0001029) | 1.89903598 |
| 128 | Athetosis (HP:0002305) | 1.89284828 |
| 129 | Myotonia (HP:0002486) | 1.88296270 |
| 130 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.86647041 |
| 131 | Pointed chin (HP:0000307) | 1.86592071 |
| 132 | Sleep apnea (HP:0010535) | 1.85756944 |
| 133 | Mutism (HP:0002300) | 1.84910899 |
| 134 | Pancreatitis (HP:0001733) | 1.84752605 |
| 135 | Hyperphosphatemia (HP:0002905) | 1.84680634 |
| 136 | Abnormality of the columella (HP:0009929) | 1.84409223 |
| 137 | Neuronal loss in central nervous system (HP:0002529) | 1.84374573 |
| 138 | Stereotypic behavior (HP:0000733) | 1.83914825 |
| 139 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 1.82997733 |
| 140 | Spastic tetraparesis (HP:0001285) | 1.82570428 |
| 141 | Renal salt wasting (HP:0000127) | 1.82240170 |
| 142 | Dyskinesia (HP:0100660) | 1.82226371 |
| 143 | Hypoplasia of the odontoid process (HP:0003311) | 1.82137776 |
| 144 | Absent speech (HP:0001344) | 1.81760277 |
| 145 | Clonus (HP:0002169) | 1.80419390 |
| 146 | Failure to thrive in infancy (HP:0001531) | 1.79817670 |
| 147 | Panhypogammaglobulinemia (HP:0003139) | 1.79694496 |
| 148 | Tracheomalacia (HP:0002779) | 1.79525522 |
| 149 | Severe combined immunodeficiency (HP:0004430) | 1.78782562 |
| 150 | Dysautonomia (HP:0002459) | 1.78201278 |
| 151 | Diaphragmatic weakness (HP:0009113) | 1.76940469 |
| 152 | Macroorchidism (HP:0000053) | 1.76789095 |
| 153 | Loss of speech (HP:0002371) | 1.75504056 |
| 154 | Delayed CNS myelination (HP:0002188) | 1.74962274 |
| 155 | Dysphonia (HP:0001618) | 1.74688243 |
| 156 | Hypochromic microcytic anemia (HP:0004840) | 1.72931956 |
| 157 | Insomnia (HP:0100785) | 1.72867687 |
| 158 | Slow progression (HP:0003677) | 1.71081961 |
| 159 | Psychosis (HP:0000709) | 1.70341876 |
| 160 | Hypoplastic nipples (HP:0002557) | 1.69779720 |
| 161 | Distal upper limb amyotrophy (HP:0007149) | 1.69312467 |
| 162 | Upper limb amyotrophy (HP:0009129) | 1.69312467 |
| 163 | Obstructive sleep apnea (HP:0002870) | 1.68379034 |
| 164 | EEG with generalized epileptiform discharges (HP:0011198) | 1.65463382 |
| 165 | Hepatoblastoma (HP:0002884) | 1.63162788 |
| 166 | Generalized hypotonia (HP:0001290) | 1.62866755 |
| 167 | Incomplete penetrance (HP:0003829) | 1.61642434 |
| 168 | Astrocytoma (HP:0009592) | 1.61398326 |
| 169 | Abnormality of the astrocytes (HP:0100707) | 1.61398326 |
| 170 | Turricephaly (HP:0000262) | 1.60935126 |
| 171 | Epileptiform EEG discharges (HP:0011182) | 1.60025539 |
| 172 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.59205637 |
| 173 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.57634716 |
| 174 | Narrow nasal bridge (HP:0000446) | 1.53913892 |
| 175 | Generalized myoclonic seizures (HP:0002123) | 1.52359091 |
| 176 | Abnormal EKG (HP:0003115) | 1.52222342 |
| 177 | Spinal canal stenosis (HP:0003416) | 1.51342601 |
| 178 | Confusion (HP:0001289) | 1.49777684 |
| 179 | Abnormality of the salivary glands (HP:0010286) | 1.49604289 |
| 180 | Malignant neoplasm of the central nervous system (HP:0100836) | 1.49467239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.38256336 |
| 2 | RIPK1 | 3.25315731 |
| 3 | MAP3K9 | 3.03052096 |
| 4 | CAMKK2 | 2.85988284 |
| 5 | NTRK2 | 2.85506199 |
| 6 | WNK1 | 2.74886340 |
| 7 | MAPKAPK3 | 2.67778466 |
| 8 | TYRO3 | 2.47886385 |
| 9 | GRK5 | 2.47755895 |
| 10 | MAP3K4 | 2.35734890 |
| 11 | PAK6 | 2.26619853 |
| 12 | STK38 | 2.19690551 |
| 13 | NTRK1 | 2.16847219 |
| 14 | CAMKK1 | 2.15901536 |
| 15 | MARK1 | 2.15113234 |
| 16 | MINK1 | 2.13873018 |
| 17 | TESK2 | 10.7871073 |
| 18 | MAP2K4 | 1.92319673 |
| 19 | UHMK1 | 1.73952172 |
| 20 | INSRR | 1.70403874 |
| 21 | ARAF | 1.65747712 |
| 22 | PRPF4B | 1.53318275 |
| 23 | SIK2 | 1.47108054 |
| 24 | MAP2K7 | 1.46485479 |
| 25 | DAPK2 | 1.43072716 |
| 26 | CDK12 | 1.42954767 |
| 27 | CDK19 | 1.42575436 |
| 28 | ICK | 1.33461823 |
| 29 | CAMK4 | 1.32874410 |
| 30 | TNIK | 1.31089327 |
| 31 | ALK | 1.31005207 |
| 32 | CDC42BPA | 1.28734964 |
| 33 | PRKCG | 1.27540958 |
| 34 | DDR2 | 1.27164096 |
| 35 | STK11 | 1.20704965 |
| 36 | PINK1 | 1.18191598 |
| 37 | PHKG2 | 1.17512992 |
| 38 | PHKG1 | 1.17512992 |
| 39 | EEF2K | 1.13373025 |
| 40 | CAMK1G | 1.12893834 |
| 41 | CAMK1 | 1.12748753 |
| 42 | VRK2 | 1.12611562 |
| 43 | RIPK4 | 1.10296215 |
| 44 | CDK5 | 1.09113928 |
| 45 | PKN2 | 1.08100465 |
| 46 | HIPK2 | 1.07601147 |
| 47 | ITK | 1.05824794 |
| 48 | PNCK | 1.05722653 |
| 49 | KDR | 1.05564189 |
| 50 | MARK2 | 1.05058999 |
| 51 | MATK | 1.04460734 |
| 52 | SGK223 | 1.04130420 |
| 53 | SGK494 | 1.04130420 |
| 54 | ERN1 | 1.00326854 |
| 55 | LATS2 | 1.00322955 |
| 56 | BMX | 0.97327030 |
| 57 | MAP3K13 | 0.96616466 |
| 58 | PDGFRA | 0.95796734 |
| 59 | PRKCH | 0.95704454 |
| 60 | PBK | 0.94530293 |
| 61 | FER | 0.93331240 |
| 62 | CDK15 | 0.93279755 |
| 63 | SGK2 | 0.90797421 |
| 64 | SGK3 | 0.90052884 |
| 65 | SIK3 | 0.89217815 |
| 66 | CDK18 | 0.88384965 |
| 67 | MAPK11 | 0.88336491 |
| 68 | IKBKB | 0.86926666 |
| 69 | MAPK13 | 0.85811777 |
| 70 | DYRK3 | 0.84829236 |
| 71 | DYRK1A | 0.84697098 |
| 72 | CDK11A | 0.83028260 |
| 73 | PIM2 | 0.82566390 |
| 74 | OXSR1 | 0.82504599 |
| 75 | TRIB3 | 0.76119649 |
| 76 | MAP3K6 | 0.75509887 |
| 77 | MAP2K2 | 0.75021753 |
| 78 | ZAP70 | 0.74673402 |
| 79 | TNK2 | 0.73076355 |
| 80 | SYK | 0.72362730 |
| 81 | CDK14 | 0.71699508 |
| 82 | PRKD3 | 0.71430530 |
| 83 | PTK2 | 0.69258129 |
| 84 | MST4 | 0.67996737 |
| 85 | SRPK1 | 0.66976914 |
| 86 | MAPK10 | 0.66867335 |
| 87 | CAMK2A | 0.66195826 |
| 88 | RET | 0.66121194 |
| 89 | KSR2 | 0.66046890 |
| 90 | GRK1 | 0.65648372 |
| 91 | RPS6KA3 | 0.65101712 |
| 92 | SGK1 | 0.64728040 |
| 93 | TXK | 0.64556781 |
| 94 | MAP4K1 | 0.64338248 |
| 95 | STK24 | 0.64173317 |
| 96 | STK39 | 0.63421802 |
| 97 | MAPK7 | 0.63017898 |
| 98 | ROCK2 | 0.61397363 |
| 99 | FLT3 | 0.59967433 |
| 100 | KSR1 | 0.59814090 |
| 101 | NEK6 | 0.57624696 |
| 102 | MAPKAPK5 | 0.57594507 |
| 103 | PRKAA1 | 0.57342050 |
| 104 | MAP4K2 | 0.56700296 |
| 105 | RPS6KA5 | 0.56196686 |
| 106 | PRKD2 | 0.55871288 |
| 107 | LMTK2 | 0.55710495 |
| 108 | PAK3 | 0.54831131 |
| 109 | CAMK2G | 0.54417118 |
| 110 | TBK1 | 0.54081358 |
| 111 | NME2 | 0.53963070 |
| 112 | SIK1 | 0.53170487 |
| 113 | DAPK1 | 0.52741704 |
| 114 | MAPK12 | 0.52696767 |
| 115 | PTK6 | 0.51909589 |
| 116 | TIE1 | 0.49608232 |
| 117 | LYN | 0.49354269 |
| 118 | CAMK1D | 0.48986100 |
| 119 | PRKG1 | 0.48426011 |
| 120 | EPHA2 | 0.47968250 |
| 121 | PRKCI | 0.47942980 |
| 122 | AKT3 | 0.47312377 |
| 123 | PIK3CA | 0.46508984 |
| 124 | ERBB2 | 0.46243034 |
| 125 | BCKDK | 0.45682905 |
| 126 | CASK | 0.45161255 |
| 127 | CAMK2D | 0.44850815 |
| 128 | SMG1 | 0.44642110 |
| 129 | GRK7 | 0.43708683 |
| 130 | PLK2 | 0.43465693 |
| 131 | CAMK2B | 0.43460964 |
| 132 | MAPK8 | 0.43029017 |
| 133 | ADRBK1 | 0.42701573 |
| 134 | CCNB1 | 0.42297864 |
| 135 | MST1R | 0.42021025 |
| 136 | FYN | 0.41412321 |
| 137 | CDK7 | 0.40764433 |
| 138 | CSNK1E | 0.40718172 |
| 139 | PTK2B | 0.39534851 |
| 140 | MAPK15 | 0.39434503 |
| 141 | GSK3B | 0.39412341 |
| 142 | ADRBK2 | 0.39182192 |
| 143 | PRKACA | 0.38671313 |
| 144 | KIT | 0.37184087 |
| 145 | RPS6KC1 | 0.36987380 |
| 146 | RPS6KL1 | 0.36987380 |
| 147 | SCYL2 | 0.36934082 |
| 148 | MAPK9 | 0.36614652 |
| 149 | GRK6 | 0.36053799 |
| 150 | RPS6KA6 | 0.35775288 |
| 151 | AKT2 | 0.33895685 |
| 152 | BTK | 0.30205551 |
| 153 | PRKD1 | 0.29793657 |
| 154 | ZAK | 0.28707661 |
| 155 | ATR | 0.28471875 |
| 156 | MTOR | 0.27788836 |
| 157 | LRRK2 | 0.26143200 |
| 158 | JAK3 | 0.22925919 |
| 159 | MAP3K7 | 0.22671188 |
| 160 | PRKCD | 0.22242763 |
| 161 | CLK1 | 0.22043791 |
| 162 | EPHA3 | 0.20282092 |
| 163 | DYRK1B | 0.19796928 |
| 164 | CDK9 | 0.18913924 |
| 165 | RPS6KA2 | 0.18471239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.14842608 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.20333336 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.47148927 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 3.03152261 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.02856037 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.86575068 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.76452991 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.74757181 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.74408547 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.65497040 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.62220552 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.57637965 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.54353565 |
| 14 | Long-term depression_Homo sapiens_hsa04730 | 2.52002543 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.37506285 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 2.35100677 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 2.29447420 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 2.23511235 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.21700174 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.19492791 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.97932147 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.90962589 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.85738673 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85589285 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.82587343 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.82310280 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.79233257 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.73683067 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.72099806 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.70245436 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69077417 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64282828 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.58997723 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.57006535 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.55381483 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.52297598 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.49089886 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48918780 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.47982262 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47519486 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.44312364 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43887025 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.42234132 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.37171736 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 1.35529085 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.33500112 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31446617 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27417737 |
| 49 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.26426980 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.20507477 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.17339202 |
| 52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.16438108 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.16050729 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16041928 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.14768353 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10414756 |
| 57 | Cocaine addiction_Homo sapiens_hsa05030 | 1.09608193 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08390782 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 1.03008319 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01248175 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01239522 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 1.00312159 |
| 63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.00178958 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.99571064 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98574701 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94627183 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93805092 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.93494640 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92140255 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.91776388 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91650086 |
| 72 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.88490576 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.88478172 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88081344 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.88033998 |
| 76 | Melanogenesis_Homo sapiens_hsa04916 | 0.87887371 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86664930 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84523863 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.84112644 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83414773 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83299626 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.83217300 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82383683 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81774088 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81284488 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80049903 |
| 87 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77269188 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76679504 |
| 89 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76558828 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74919120 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74343492 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.73157045 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.72254381 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71099911 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71000557 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70852772 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70816516 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70577246 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67292726 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.66302075 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64956664 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64366933 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62992271 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62066044 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.61637863 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.61042413 |
| 107 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58327427 |
| 108 | Leishmaniasis_Homo sapiens_hsa05140 | 0.56929327 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55736775 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.54654576 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54126414 |
| 112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53374898 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53191627 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52276548 |
| 115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48510108 |
| 116 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46343155 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45003843 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44754704 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44664104 |
| 120 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44645305 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44237356 |
| 122 | ABC transporters_Homo sapiens_hsa02010 | 0.44026938 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.42499181 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.39992036 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39833521 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39107271 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38644007 |
| 128 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38545766 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.37407099 |
| 130 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36910835 |
| 131 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36719179 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36219420 |
| 133 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.35974982 |
| 134 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.34757527 |
| 135 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34710550 |
| 136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34273867 |
| 137 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34023696 |
| 138 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33874536 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33696283 |
| 140 | Tight junction_Homo sapiens_hsa04530 | 0.33577131 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31849039 |
| 142 | Platelet activation_Homo sapiens_hsa04611 | 0.31806114 |
| 143 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31683323 |
| 144 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31602629 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30537057 |
| 146 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.30507353 |
| 147 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29231674 |
| 148 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.26849302 |
| 149 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26395274 |
| 150 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.20969790 |
| 151 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.18788840 |
| 152 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.15119241 |

